Eveliqure Biotechnologies

Developing a vaccine against Diarrhea using a proprietary technology platform

placeVienna, Vienna, Austria calendar_todayFounded 2012 groups7 employees language eveliqure.com

Social engagement

Social engagement: 608 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital343%
Private equity114%
Accelerator & incubator114%
Other / undisclosed229%

Recent activity

20 Mar 2026
Partnership
Serum Institute of India (SII)
23 Jul 2025
Milestone
regulatory
Coming soon